Home › Metastatic Cancer › Kansas
Metastatic Cancer clinical trials in Kansas
15 studies for Metastatic Cancer are looking for participants at sites in Kansas.
Cities in Kansas
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- University of Kansas Cancer Center, Fairway
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07562152A Study of ASP3082 in Adults With Advanced Solid Tumors
- University of Kansas Medical Center, Westwood
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05382559First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
- University of Kansas Medical Center, Westwood
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05875168Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05803382A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- United Imaging Consultants, Lenexa
- MidAmerica Cancer Care- American Oncology Partners, Merriam
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- The University of Kansas Medical Center, Westwood
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06915753A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Kansas Cancer Center - Westwood, Westwood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- AMR Kansas City Oncology, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- and 2 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT05691491LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- University of Kansas Cancer Center, Westwood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT06216301Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- The University of Kansas Cancer Center, Westwood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06757634A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- University of Kansas Cancer Center, Westwood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT06064877A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- The University of Kansas Cancer Center, Fairway
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT06244771Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- Ascension Via Christi Hospitals Wichita, Wichita
- Cancer Center of Kansas - Wichita, Wichita
RecruitingObservational study
2 Months · All sexes · Updated Mar 5, 2026 · NCT02474160A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Wichita Urology Group, Wichita
RecruitingPhase 1
Ages 18 and older · Men · Updated Feb 4, 2026 · NCT04729114From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.